These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35805924)

  • 81. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
    Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
    PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review.
    Ruhé HG; Huyser J; Swinkels JA; Schene AH
    J Clin Psychiatry; 2006 Dec; 67(12):1836-55. PubMed ID: 17194261
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Future directions for serotonin and antidepressants.
    Artigas F
    ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.
    Madhusoodanan S; Alexeenko L; Sanders R; Brenner R
    Ann Clin Psychiatry; 2010 Aug; 22(3):148-56. PubMed ID: 20680187
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test.
    Page ME; Detke MJ; Dalvi A; Kirby LG; Lucki I
    Psychopharmacology (Berl); 1999 Nov; 147(2):162-7. PubMed ID: 10591883
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
    Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
    Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use of antidepressant medications: are there differences in psychiatric visits among patient treatments in the Veterans Administration?
    Hamed A; Lee A; Ren XS; Miller DR; Cunningham F; Zhang H; Kazis LE
    Med Care; 2004 Jun; 42(6):551-9. PubMed ID: 15167323
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Vortioxetine: a New Treatment for Major Depressive Disorder.
    Connolly KR; Thase ME
    Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I
    Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.
    Kanner AM
    Epilepsy Behav; 2016 Aug; 61():282-286. PubMed ID: 27236241
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hippocampal mossy cell involvement in behavioral and neurogenic responses to chronic antidepressant treatment.
    Oh SJ; Cheng J; Jang JH; Arace J; Jeong M; Shin CH; Park J; Jin J; Greengard P; Oh YS
    Mol Psychiatry; 2020 Jun; 25(6):1215-1228. PubMed ID: 30837688
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.
    Mukai Y; Tampi RR
    Clin Ther; 2009 May; 31(5):945-61. PubMed ID: 19539096
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
    Thériault O; Poulin H; Beaulieu JM; Chahine M
    Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
    Mitchell NC; Gould GG; Smolik CM; Koek W; Daws LC
    Front Pharmacol; 2013; 4():131. PubMed ID: 24191152
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
    Vlahiotis A; Devine ST; Eichholz J; Kautzner A
    J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.